leukemia

Children In China Diagnosed With Leukemia After Taking Chinese Vaccines

There has been a rise in patients from the younger age group in the last few months, coinciding with the regime’s push to inoculate children between 3 and 11 years old. More than half of the population of children in that age bracket have been vaccinated. Parents and children were reportedly coerced into vaccination.

Study: Cigarettes are Behind a Shocking 30% of Cancer Deaths

It may be common knowledge that smoking cigarettes leads to a host of diseases and early death, but did you know that 30% of all cancer deaths are smoking-related? This is according to a study published in JAMA Internal Medicine. [1]
Smoking is the biggest preventable cause of death from cancer and other diseases, yet 40 million people continue to puff away on cigarettes, according to U.S. researchers from the American Cancer Society (ACS).

Brain Cancer Now Deadlier than Leukemia for Children, Report Shows

Federal data has emerged demonstrating that brain cancer is now the deadliest form of cancer for children and teens. Previously, leukemia was the cancer that was most fatal for children.
According to the data provided by the Centers for Disease Control, in 1999, 1 in 3 children who died of cancer died of leukemia. One in four children with fatal cancer had brain cancer. By 2014, the numbers had reversed. [1]
The report stated:

Cord-Blood Transplants Provide Fresh Hope for Leukemia Patients

The lives of both adults and children with leukemia can be saved with bone marrow or stem cell transplants, but it’s difficult to find a match. Well, a new study shows that (umbilical) cord-blood may work just as well, if not better. [1]
Lead study author Dr. Filippo Milano says:

“Often, cord-blood transplant is thought to be only as the last resource for patients without donors. But cord blood does not have to be considered only an alternative donor source. In centers with experience, it can yield to great outcomes.”

Cancer Study Halted After 3 People Die

U.S. regulators in July of 2016 halted a trial of Juno Therapeutics Inc.’s experimental cancer therapy, known as JCAR015, after three patients died.
JCAR015 uses genetically engineered cells as a treatment for cancer. However, one of the pursuits in oncology was temporarily halted by the FDA when some of the participants developed fatal swelling in the brain.
Hans Bishop, Juno’s chief executive, said in a conference call with securities analysts that the deaths were “difficult and humbling for everyone involved.”

Radiation and Cancer: Risks of Leukemia in Nuclear Workers More Than Double Previous Estimate

By Ian Fairlie | CounterPunch | October 16, 2015 In 2013, I discussed several epidemiological studies providing good evidence of radiogenic risks at very low exposure levels. A powerful new study has been published in Lancet Haematology [1] which adds to this evidence. However the study’s findings are more important than the previous studies, for […]